HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

Chimeric antigen receptor (CAR) - T cell therapy is a new class of cellular immunotherapies, which has made great achievements in the treatment of malignant tumors. Despite improvements in colorectal cancer (CRC) therapy, treatment of many patients fails because of metastasis and recurrence. The hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Meng, Qingtao, Sun, Hao, Zhang, Xinwei, Yun, Jun, Li, Bin, Wu, Shenshen, Li, Xiaobo, Yang, Hongbao, Zhu, Haitao, Aschner, Michael, Relucenti, Michela, Familiari, Giuseppe, Chen, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627513/
https://www.ncbi.nlm.nih.gov/pubmed/34839348
http://dx.doi.org/10.1038/s41419-021-04100-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627513/
https://www.ncbi.nlm.nih.gov/pubmed/34839348
http://dx.doi.org/10.1038/s41419-021-04100-0

Ejemplares similares